Evidence map›Paper›PMID 30444315›Full record

Trial reportJournal of clinical hypertension (Greenwich, Conn.)2018

Home blood pressure control status in 2017-2018 for hypertension specialist centers in Asia: Results of the Asia BP@Home study.

Kazuomi Kario, Naoko Tomitani, Peera Buranakitjaroen, Yook-Chin Chia, Sungha Park, Chen-Huan Chen, Romeo Divinagracia, Jinho Shin, Saulat Siddique, Jorge Sison and 12 more

Open access · bronzeAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Journal of clinical hypertension (Greenwich, Conn.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Target blood pressure and control status in Asia.Journal of clinical hypertension (Greenwich, Conn.) · 2020
    Trial
  3. Trial
  4. Blood pressure status, JSH 2019-based control rate, and associated factors among community-dwelling adults: The NOSE study.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. 2022 Thai Hypertension Society guidelines on home blood pressure monitoring.Journal of clinical hypertension (Greenwich, Conn.) · 2022
    Article
  10. The HOPE Asia Network activity 2022: Towards better hypertension management in Asia.Journal of clinical hypertension (Greenwich, Conn.) · 2022
    Article
  11. Latest hypertension research to inform clinical practice in Asia.Hypertension research : official journal of the Japanese Society of Hypertension · 2022
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. One more step toward an Asian hypertension guideline.Journal of clinical hypertension (Greenwich, Conn.) · 2021
    Article
  17. Article
  18. Review
  19. Article
  20. Hypertension and stroke in Asia: A comprehensive review from HOPE Asia.Journal of clinical hypertension (Greenwich, Conn.) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 16 institutions in 12 countries.

Kazuomi KarioDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.ORCID 0000-0002-8251-4480
Naoko TomitaniDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
Peera BuranakitjaroenDepartment of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Yook-Chin ChiaDepartment of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Selangor Darul Ehsan, Malaysia.
Sungha ParkDivision of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, Korea.
Chen-Huan ChenDepartment of Medicine, Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan.
Romeo DivinagraciaUniversity of the East Ramon Magsaysay Memorial Medical Center Inc, Quezon City, Philippines.
Jinho ShinFaculty of Cardiology Service, Hanyang University Medical Center, Seoul, Korea.
Saulat SiddiquePunjab Medical Center, Lahore, Pakistan.
Jorge SisonDepartment of Medicine, Medical Center Manila, Ermita, Manila, Philippines.
Arieska Ann SoenartaDepartment of Cardiology and Vascular Medicine, University of Indonesia-National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia.
Guru Prasad SogunuruMIOT International Hospital, Chennai, India.
Jam Chin TayDepartment of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore.
Yuda TuranaDepartment of Neurology, Faculty of Medicine, Atma Jaya Catholic University of Indonesia, North Jakarta, Jakarta, Indonesia.
Yuqing ZhangDivisions of Hypertension and Heart Failure, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Jennifer NailesUniversity of the East Ramon Magsaysay Memorial Medical Center Inc, Quezon City, Philippines.
Sirisawat WanthongDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
Satoshi HoshideDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.ORCID 0000-0001-7541-5751
Noriko MatsushitaOmron Healthcare Singapore, Pte. Ltd, Singapore, Singapore.
Hiroshi KanegaeDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
Ji-Guang WangDepartment of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.ORCID 0000-0001-8511-1524
HOPE Asia Network
Jichi Medical University · JPSiriraj Hospital · THUniversity of the East Ramon Magsaysay Memorial Medical Center · PHAtma Jaya Catholic University of Indonesia · IDChinese Academy of Medical Sciences & Peking Union Medical College · CNHanyang University Medical Center · KRMadras Institute of Orthopaedics and Traumatology · INNational Yang Ming Chiao Tung University · TWOmron (Japan) · JPPelita Harapan University · IDPunjab Medical Center · PKRuijin Hospital · CNTan Tock Seng Hospital · SGUniversity of Malaya · MYUniversity of the Philippines Manila · PHYonsei University Health System · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A self-measured home blood pressure (BP)-guided strategy is an effective practical approach to hypertension management. The Asia BP@Home study is the first designed to investigate current home BP control status in different Asian countries/regions using standardized home BP measurements taken with the same validated home BP monitoring device with data memory. We enrolled 1443 medicated hypertensive patients from 15 Asian specialist centers in 11 countries/regions between April 2017 and March 2018. BP was relatively well controlled in 68.2% of patients using a morning home systolic BP (SBP) cutoff of <135 mm Hg, and in 55.1% of patients using a clinic SBP cutoff of <140 mm Hg. When cutoff values were changed to the 2017 AHA/ACC threshold (SBP <130 mm Hg), 53.6% of patients were well controlled for morning home SBP. Using clinic 140 mm Hg and morning home 135 mm Hg SBP thresholds, the proportion of patients with well-controlled hypertension (46%) was higher than for uncontrolled sustained (22%), white-coat (23%), and masked uncontrolled (9%) hypertension, with significant country/regional differences. Home BP variability in Asian countries was high, and varied by country/region. In conclusion, the Asia BP@Home study demonstrated that home BP is relatively well controlled at hypertension specialist centers in Asia. However, almost half of patients remain uncontrolled for morning BP according to new guidelines, with significant country/regional differences. Strict home BP control should be beneficial in Asian populations. The findings of this study are important to facilitate development of health policies focused on reducing cardiovascular complications in Asia.

Indexed as

AgedAmbulatory Care FacilitiesAntihypertensive AgentsAsiaBlood PressureBlood Pressure DeterminationBlood Pressure Monitoring, AmbulatoryFemaleHumansHypertensionMaleMasked HypertensionMiddle AgedObserver VariationPrevalenceProspective StudiesAntihypertensive AgentsAsiaAsia BP@Home studyblood pressure controlblood pressure variabilityhome blood pressureHome studyvalidated blood pressure monitoring device

Identifiers

PMID30444315
PMCPMC8031357
OpenAlexW2901476808

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.